CMR Molecular Imaging Announces the Installation of a Breast PET Imaging System at Baheya Breast Cancer Center

Thursday, November 21, 2019 Cancer News
Email Print This Page Comment bookmark
Font : A-A+

CMR Molecular Imaging selected by Baheya Breast Cancer Center as the provider of a High Resolution Breast PET Imaging System

CARLSBAD, Calif., Nov. 21, 2019 /PRNewswire-PRWeb/ -- CMR Molecular Imaging and its representative in Egypt, Global Technology, have been selected by the Baheya Breast Cancer Center to provide a Solo II™ High Resolution Breast PET Imaging (BPI) System with biopsy guidance capabilities.

The Solo II High Resolution PET System provides metabolic visualization of lesions in small body parts. Through a unique combination of gentle immobilization, advanced photonics and imaging processing, the scanner provides tomographic images with a resolution as small as 1.6 mm. The Stereo Navigator® PET Guided Biopsy Accessory, the only FDA cleared PET biopsy guidance device, confirms a biopsy path with a 3-D needle trajectory image that enables physicians to target and guide biopsy devices to obtain adequate tissues samples for pathologic evaluation.

"The addition of a Solo II Breast PET Imaging System to our institution is part of the vision of the Baheya Foundation of equipping the Breast Cancer Center with the most advanced technology for early detection, treatment planning and monitoring of breast cancer," said Dr. Mohamed Gomaa, Director of Imaging of the Center.

"It is an honor that the Baheya Foundation is incorporating the CMR breast PET technology to their path of care in order to significantly improve cancer detection and treatment for their patients," said Dr. Jenny Matsiota, CMR Molecular Imaging International Business Development Manager.

About Baheya Breast Cancer Center: Baheya Breast Cancer Center is a 5 floor, 10,000 square meter, facility, operated by The Baheya Foundation for Early Detection and Treatment of Breast Cancer. The Foundation was established by the family of Mrs. Baheya Wahby who was diagnosed and passed away after losing her battle with cancer. During her treatment the family noticed the amount of suffering women from low income families go through being unable to afford the treatment. To honor her memory, all stages of treatment are free, from early detection, surgery, chemo and radiation therapy, psychological, clinical nutrition and therapeutic therapy. For information visit

About CMR Molecular Imaging: CMR Molecular Imaging, is a unit of CMR Naviscan Corporation, a leader in organ-specific molecular imaging and part of the Compańia Mexicana de Radiologia CGR, S.A. de C.V. (CMR), a global developer and manufacturer of high quality diagnostic imaging equipment and healthcare information systems, including DICOM-compliant imaging software. CMR Naviscan, headquartered in Carlsbad, California, develops and manufactures molecular imaging systems, including the Solo II™ High Resolution Breast PET Imaging (BPI) scanner, the Stereo Navigator® Accessory, and the LumaGEM® Molecular Breast Imaging (MBI) system. CMR Naviscan is US FDA registered and ISO 13485:2012 certified. For more information visit

About Global Technology: Global Technology has been serving the Egyptian healthcare sector for more than 23 years providing both sales and after sales services. The company employs close to 200 people and has installed close to 4,500 medical equipment. It represents leading manufacturers of medical equipment – mainly diagnostic imaging. For more information visit


SOURCE CMR Molecular Imaging

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z



Premium Membership Benefits

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store